Compare Hecla Mining Company Common Stock (HL) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hecla Mining Company Common Stock vs Heron Therapeutics Inc — how do they compare? Hecla Mining Company Common Stock trades at $17.05 (market cap $11.24B), while Heron Therapeutics Inc trades at $0.37 (market cap $68.01M). The key difference: Hecla Mining Company Common Stock is far larger — about 165.3× Heron Therapeutics Inc's market cap, and Hecla Mining Company Common Stock pays a 0.09% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hecla Mining Company Common Stock for 0 Days and Heron Therapeutics Inc for 35 Days on average.
| HL | HRTX | |
|---|---|---|
Market Cap | $11.24B | $68.01M |
Volume | 37,227,749 | 1,891,941 |
Sector | Basic Materials | Health |
52-Week High | $31.81 | $1.49 |
52-Week Low | $11.97 | $0.27 |
Typical Hold Time | 0 Days | 35 Days |
Enterprise Value | $10.77B | $174.75M |
Dividend Yield | 0.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hecla Mining Company Common Stock
Hecla Mining is a precious metals producer focused on silver and gold. It operates mines in the United States and Canada.
Read more on HL →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
